“…However, obtaining precise control over the pore size and biodegradation of hydrogel networks might emerge as a serious issue in obtaining controlled release profiles in the presence of a recurring and metastatic cancer type like ovarian cancer or glioma [ 12 , 13 , 14 , 15 , 16 ]. In particular, natural and hydrophilic pH-responsive polymers, such as alginate, chitosan, and gelatin, were shown to liberate internally loaded active agents more rapidly due to their high degradation rate in tumor environments [ 17 , 18 , 19 ] compared to polyanhydride- and polyester-based synthetic polymers (i.e., poly(glycolide-co-sebacate) (PGS), poly (caprolactone) (PCL), and poly (lactide-co-glycolide) (PLGA)) [ 20 , 21 , 22 , 23 , 24 ]. Thus, an urgent need has evolved for hydrogels with tunable properties for the slower and sustained release of therapeutic agents.…”